NCT07442617

Brief Summary

Asthma and chronic obstructive pulmonary disease (COPD) are among the most prevalent chronic respiratory conditions worldwide, affecting hundreds of millions of individuals and contributing substantially to morbidity, mortality, and healthcare burden. Although clinicians routinely advise patients verbally on inhaler use, the lack of structured, hands-on education results in significant variation in technique and consistently poor retention of skills over time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

February 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

1 month

First QC Date

February 24, 2026

Last Update Submit

February 27, 2026

Conditions

Keywords

Inhaler techniquenurse-led inhaler educationBronchial Asthma

Outcome Measures

Primary Outcomes (1)

  • impact of nurse-led education on inhaler technique

    Participants will be evaluated to assess the impact of nurse-led education on technique Score: 152 This score evaluates the patient's ability to correctly use their inhaler. It covers nine key 153 components: ensuring the prescribed device type is used (MDI, DPI, or nebulizer), shaking 154 the MDI before use, complete exhalation before inhalation, proper lip seal around the 155 mouthpiece or spacer, correct inhalation speed according to device type, holding breath after 156 inhalation, rinsing the mouth after corticosteroid sprays, correct use of spacer devices, and 157 overall error correction. The maximum possible score is 9 points. Scores are interpreted as 158 follows: ≥8 indicates excellent technique, 5-7 represents moderate performance, and ≤4 159 indicates poor technique. The checklist was adapted from guideline-recommended inhaler 160 technique steps according to GINA and GOLD reports

    1 month

Study Arms (2)

nurse-led inhaler education

ACTIVE COMPARATOR

Known Patients with asthma or COPD, using inhalers and education was Conducted by trained nurses using standardized checklist (Global Initiative for Asthma "GINA"/Global Initiative for Chronic Obstructive Lung Disease "GOLD")

Procedure: Inhaler technique

Control group on inhaler

NO INTERVENTION

Known Patients with asthma or COPD, using inhalers weren't trained

Interventions

Patient Education: Conducted by trained nurses using standardized checklist (GINA/GOLD)

nurse-led inhaler education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥18 years diagnosed with Asthma or COPD according to GINA / GOLD guidelines
  • Current use of inhaler therapy (MDI, DPI, or Nebulizer) for ≥3 months.
  • Able to understand instructions and perform inhaler technique assessments.
  • Willing to provide informed consent and participate in all study assessments.

You may not qualify if:

  • Acute exacerbation requiring hospitalization at the time of enrollment.
  • Cognitive impairment or neurological disorders preventing understanding or proper inhaler use.
  • Severe comorbidities (e.g., advanced heart failure, end-stage renal disease) that limit participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed AbdElmoniem

Al Mansurah, 35516, Egypt

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Mohamed AbdElmoniem

    Lecturer of chest medicine faculty of medicine Mansoura university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Assess the effect of nurse-led inhaler education on patients' inhaler technique
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer faculty of medicine

Study Record Dates

First Submitted

February 24, 2026

First Posted

March 2, 2026

Study Start

December 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

March 2, 2026

Record last verified: 2026-02

Locations